Recent advances in technology and data science mean that there is more data about people, their habits and their health than ever before, but clinical utility cannot be fully realised without successful integration and analysis.
The sixth Innovation Academy event was held last December in London. This one-day Viapath meeting was divided into four sessions and included presentation of the CQI in Healthcare and the Excellence in Pathology awards. The following selected abstracts reflect the diverse content of this very successful series of meeting.
Antimicrobial resistance – what can we learn from control of the MRSA epidemic?
Methicillin-resistant Staphylococcus aureus (MRSA) was the scourge of hospitals in the 1990s, with the UK having the highest rates in Europe. From 2001, hospital MRSA rates were published for all to see, with Guy’s, St Thomas’ and King’s College hospitals having some of the highest rates in the country. In 2004 the government set an ambitious target to reduce rates by 50%, prompting a national infection control campaign with publication of The Health Act, hospital inspections, national guidance, strengthened board accountability, education and training in basic infection control (hand hygiene, barrier nursing and isolation), and targeted measures, particularly universal screening and decolonisation.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.